Health Canada
- Status: approved
Application of crisaborole twice daily (Application of crisaborole twice daily) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Cairo University is the originator. The local marketing authorisation holder may differ — check the official source linked above.